{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:04:05Z","timestamp":1785380645692,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.euroneuro.2010.07.003","type":"journal-article","created":{"date-parts":[[2010,8,22]],"date-time":"2010-08-22T04:39:31Z","timestamp":1282451971000},"page":"776-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007)"],"prefix":"10.1016","volume":"20","author":[{"given":"Rif S.","family":"El Mallakh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Rollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McQuade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2010.07.003_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"2000"},{"key":"10.1016\/j.euroneuro.2010.07.003_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1744-859X-8-27","article-title":"Treatment of psychotic symptoms in bipolor disorder with aripiprazole monotherapy: a meta-analysis","volume":"8","author":"Fountoulakis","year":"2008","journal-title":"Ann. Gen. Psychiatr."},{"issue":"7","key":"10.1016\/j.euroneuro.2010.07.003_bb0015","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1017\/S1461145708009231","article-title":"Treatment of bipolar disorder: a systematic review of available data and clinical perspectives","volume":"11","author":"Fountoulakis","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.euroneuro.2010.07.003_bb0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4088\/JCP.v66n1001","article-title":"Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"66","author":"Grant","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2010.07.003_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT(1A) receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2010.07.003_bb0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2003.10.025","article-title":"In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function","volume":"483","author":"Jordan","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.euroneuro.2010.07.003_bb0035","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.07.003_bb0110","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar l disorder: a 10-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.euroneuro.2010.07.003_bb0040","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2010.07.003_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.euroneuro.2010.07.003_bb0050","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0006-3223(99)00311-X","article-title":"Placebo effect in randomized, controlled studies of acute bipolar mania and depression","volume":"47","author":"Keck","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2010.07.003_bb0055","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2010.07.003_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2010.07.003_bb0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jad.2007.08.015","article-title":"Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder","volume":"107","author":"Suppes","year":"2008","journal-title":"J. Affect. Disorders."},{"key":"10.1016\/j.euroneuro.2010.07.003_bb0070","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/138945006778226598","article-title":"Antipsychotic medications in the treatment of bipolar disorder","volume":"7","author":"Surja","year":"2006","journal-title":"Curr. Drug Targets"},{"issue":"8","key":"10.1016\/j.euroneuro.2010.07.003_bb0075","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4088\/JCP.v68n0807","article-title":"A systematic review of placebo response in studies of bipolar mania","volume":"68","author":"Sysko","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2010.07.003_bb0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.187.3.235","article-title":"Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial","volume":"187","author":"Vieta","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2010.07.003_bb0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000082021","article-title":"The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate","volume":"74","author":"Vieta","year":"2005","journal-title":"Psychother. Psychosom."},{"issue":"4","key":"10.1016\/j.euroneuro.2010.07.003_bb0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4088\/JCP.v69n0423g","article-title":"Increasing rates of placebo response over time in mania studies","volume":"69","author":"Vieta","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2010.07.003_bb0095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0269881108099418","article-title":"Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study","volume":"24","author":"Vieta","year":"2010","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.euroneuro.2010.07.003_bb0100","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2010.07.003_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","article-title":"Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study","volume":"194","author":"Young","year":"2009","journal-title":"Br. J. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X10001598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X10001598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:49:38Z","timestamp":1760377778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X10001598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0924977X10001598"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2010.07.003","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007)","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2010.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}